XML 31 R20.htm IDEA: XBRL DOCUMENT v3.25.2
Derivative Instruments
 6 Months Ended
Jun. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments
The Company uses derivative instruments, specifically, forward foreign exchange contracts, to manage the risk associated with the volatility of future cash flows. The forward foreign exchange contracts are used to mitigate the impact of exchange rate fluctuations on certain forecasted inventory purchases and are designated as cash flow hedges.
The notional amounts of the Company’s outstanding derivative instruments as of June 30, 2025 and December 31, 2024 were as follows:
June 30, 2025December 31, 2024
Derivative instruments designated as accounting hedges:
Foreign exchange contracts$112,893 $90,031 
The fair value of the Company’s outstanding derivative instruments as of June 30, 2025 and December 31, 2024 were as follows:
Balance Sheet ClassificationJune 30, 2025December 31, 2024
Assets:
Forward contractsOther current assets$826 $2,175 
Liabilities:
Forward contractsOther current liabilities$4,675 $816 
The following table presents the pretax impact of (loss)/gains from the Company's designated derivative instruments on its Condensed Consolidated Financial Statements for the periods ended June 30, 2025 and June 30, 2024:
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Cash flow hedges:
Foreign exchange contracts$(8,709)$(124)$(5,103)$1,525 
As of June 30, 2025, the current maturity dates of the Company’s derivative instruments range from July 2025 to June 2026.
For the periods ended June 30, 2025 and 2024, the Company's hedging activities were deemed effective, with no ineffectiveness recognized in the Condensed Consolidated Statements of Operations. Gains and losses from these hedging activities are recorded in cost of sales in the Condensed Consolidated Statements of Operations.
For the periods ended June 30, 2025, the Company's settlement of certain foreign exchange forward contracts resulted in a gain of $9,252, which was recorded as gain on derivative in the Company's Condensed Consolidated Statements of Operations. These contracts were entered into to hedge foreign exchange rate risk associated with a portion of the purchase price in connection with the Kurt Geiger acquisition.